VIM and nonpapillary renal cell carcinoma: On the other hand, evidence supports that RKIP inhibits ccRCC tumorigenesis and/or metastasis via inhibiting EMT, based the observations that modulations of RKIP accordingly affected A498 invasion along with changes in vimentin expression (Fig. 6).